However, the molecular basis of these associations between BOLD-LFOs and AD remains unknown, and no studies to date have investigated how BOLD-LFOs relate to AD pathophysiology in the context of the AD risk gene, apolipoprotein-ε4 (APOE4). This evidence concerns the gene APOE and Alzheimer disease.